logo
    Supplemental Table Legends from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16<sup>+</sup> Cancers
    Lauren E. ColbertMolly B. ElErica J. LynnJulianna BronkTatiana V. KarpinetsXiaogang WuBhavana V. ChapmanTravis T. SimsDaniel LinRamez KouzyJulie SammouriGreyson BiegertAndrea Y. Delgado MedranoAdilene OlveraK. Jagannadha SastryPatricia J. EifelAnuja JhingranLilie L. LinLois M. RamondettaP. Andrew FutrealAmir A. JazaeriKathleen M. SchmelerJingyan YueAparna MitraKyoko Yoshida-CourtJennifer A. WargoTravis SolleyVenkatesh L. HegdeSita S. NookalaAnanta V. YanamandraStephanie Dorta‐EstremeraGeena MathewRohit KavukuntlaCassidy PapsoMustapha Ahmed-KaddarMin‐Soo KimJianhua ZhangAlexandre ReubenEmma B. HollidayBruce D. MinskyAlbert C. KoongEugene J. KoayPrajnan DasCullen M. TaniguchiAnn H. Klopp
    0
    Citation
    0
    Reference
    10
    Related Paper
    Abstract:
    Supplemental Table Legends<p>Supplemental Table Legends</p>
    Keywords:
    Chemoradiotherapy
    Table (database)
    Topics:
    Cervical Cancer and HPV Research
    Cancer Research and Treatments
    Molecular Biology Techniques and Applications
    PDF
    Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
    The Kaohsiung Journal of Medical Sciences (2019)
    Ming‐Yii HuangChing‐Wen HuangJaw‐Yuan Wang
    Abstract Colorectal cancer is a major public health problem worldwide, and locally advanced rectal cancer (LARC) is known for its poor prognosis. A multimodal treatment approach is the only method to achieve satisfactory local recurrence and survival rates in LARC. Determining which therapeutic modality for LARC has the most satisfactory influence on quality of life and disease outcome is still controversial. LARC treatment is subject to continuous advancement due to the development of new and better diagnostic tools, radiotherapy techniques, and chemotherapeutic agents. Herein, we review various therapeutic modalities for LARC from several aspects. In addition to radiotherapy techniques such as neoadjuvant chemoradiotherapy (NCRT), we discuss the progress of chemotherapy, appropriate time interval between NCRT and surgery, relationship between tumor location and NCRT efficacy/safety, wait‐and‐watch policy, and predictors of treatment response following NCRT. Because of the controversies and unanswered questions regarding NCRT treatments for LARC, additional investigations are required to determine which therapeutic approach is the most feasible for LARC patients.
    Chemoradiotherapy
    Modalities
    Therapeutic modalities
    Treatment modality
    Citations (16)
    Radiation Therapy Combined with Iressa for Patients with Locally Advanced Non-Small Cell Lung Cancer Who Couldn’t Receive Surgery or Concurrent Chemoradiotherapy: The Preliminary Results of a Phase II Clinical Trial
    International Journal of Radiation Oncology*Biology*Physics (2018)
    Zhixue Fu
    Chemoradiotherapy
    Univariate analysis
    Citations (0)
    Is Neoadjuvant Chemoradiotherapy Safe for Elderly Patients with Esophageal Cancer?
    Journal of the American College of Surgeons (2015)
    Geena X. WuPhilip H. G. ItuarteJoseph ChaoYi‐Jen ChenDan J. Raz
    Chemoradiotherapy
    Citations (0)
    POS-02.22: Neoadjuvant low-dose chemoradiotherapy against muscle-invasive bladder cancer: Possible improvement of survival and favorable local control for bladder-preserved patients
    Urology (2007)
    Fumitaka KogaSoichiro YoshidaYukio KageyamaSatoru KawakamiYasuhisa Fujii
    Chemoradiotherapy
    Neoadjuvant Therapy
    Citations (0)
    Chemoradiotherapy of spinal extradural Ewing sarcoma after the Fontan procedure
    Pediatrics International (2020)
    Namiko MaeharaHidetaka NiizumaTatsuya NakamuraMasato KimuraYoji Sasahara
    Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
    Chemoradiotherapy
    Citations (1)
    1035
    International Journal of Radiation Oncology*Biology*Physics (2006)
    Aaron M. AllenSteven J. MentzerDavid J. SugarbakerHarvey J. MamonElizabeth H. Baldini
    Carboplatin
    Chemoradiotherapy
    Neoadjuvant Therapy
    Citations (0)
    Treatment Efficacy Of Preoperative Chemoradiotherapy For Patients With Locally Advanced Non-small cell Lung Cancer
    International Journal of Radiation Oncology*Biology*Physics (2011)
    T. SasakiShuichiro UeharaMuneaki AbeYoshiyuki ShioyamaKazumasa Nakamura
    Chemoradiotherapy
    Tegafur
    Citations (0)
    Active Surgery Did Not Benefit Patients with Locally Advanced Rectal Cancer Who Achieved Clinical Complete Response after Neoadjuvant Chemoradiotherapy
    Journal of the American College of Surgeons (2020)
    Jin GuZihan Han
    Chemoradiotherapy
    Neoadjuvant Therapy
    Complete response
    Citations (0)
    Patterns of Failure after Definitive Surgery Followed by Adjuvant Chemoradiotherapy in Patients with Stomach Cancer
    International Journal of Radiation Oncology*Biology*Physics (2011)
    J. LiuBenjamin MouE. Liu
    Chemoradiotherapy
    Stomach cancer
    Citations (2)
    Postoperative Pulmonary Complications after Neoadjuvant Chemoradiotherapy with IMRT for Esophageal Cancer
    International Journal of Radiation Oncology*Biology*Physics (2010)
    Abraham J. WuNabil P. RizkDavid H. IlsonO. AghayereJoann Kwah
    Chemoradiotherapy
    Esophagectomy
    Neoadjuvant Therapy
    Citations (0)